RNAi screening for the discovery of novel modulators of human disease

Current Pharmaceutical Biotechnology

Volumn 11, Issue 7, 2010, Pages 735-756

  Seyhan, Attila A ^a   Ryan, Terence E ^a  

^a PFIZER INC   (United States)

Author keywords

Biomarker; RNA interference; RNAi library screen; Short hairpin RNA (shRNA); Small interfering RNA (siRNA); Synthetic lethal screen; Target discovery

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIAL RNA; BORTEZOMIB; IMATINIB; MICRORNA; PACLITAXEL; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TAMOXIFEN; TRASTUZUMAB; VIRUS RNA;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNITY; BACTERIAL VIRULENCE; BREAST CANCER; BRUCELLA; CANCER CELL; CANCER RESEARCH; CANCER RESISTANCE; CELLULAR IMMUNITY; CHEMOSENSITIZATION; CHLAMYDIA; CHRONIC MYELOID LEUKEMIA; DENGUE VIRUS; DRUG RESEARCH; DRUG RESISTANCE; DRUG SCREENING; DRUG SENSITIZATION; DRUG TARGETING; GASTROINTESTINAL STROMAL TUMOR; GENE LIBRARY; GENE SILENCING; GENE TECHNOLOGY; GENETIC SCREENING; GENOME; HEPATITIS C VIRUS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUNTINGTON CHOREA; INFLUENZA VIRUS; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; NEOPLASM; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; RNA INTERFERENCE; TUMOR SUPPRESSOR GENE; VIRUS VIRULENCE; WEST NILE FLAVIVIRUS;

ANIMALS; COMMUNICABLE DISEASES; DRUG DISCOVERY; GENE LIBRARY; GENE TARGETING; GENETIC TESTING; HUMANS; INFLAMMATION; NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

BACTERIA (MICROORGANISMS);

EID: 78649286116     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110792927766     Document Type: Article

References (106)

1. Collins, I.; Workman, P. New approaches to molecular cancer therapeutics. Nat. Chem. Biol., 2006, 2(12), 689-700.
2. Kissler, S.; Van Parijs, L. Exploring the genetic basis of disease using RNA interference. Expert. Rev. Mol. Diagn., 2004, 4(5), 645-51.
3. Kuritzkes, D. R. HIV-1 entry inhibitors: an overview. Curr. Opin. HIV AIDS, 2009, 4(2), 82-87.
4. Cobleigh, M. A.; Vogel, C. L.; Tripathy, D.; Robert, N. J.; Scholl, S.; Fehrenbacher, L.; Wolter, J. M.; Paton, V.; Shak, S.; Lieberman, G.; Slamon, D. J. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J. Clin. Oncol., 1999, 17(9), 2639-2648.
5. Vogel, C. L.; Cobleigh, M. A.; Tripathy, D.; Gutheil, J. C.; Harris, L. N.; Fehrenbacher, L.; Slamon, D. J.; Murphy, M.; Novotny, W. F.; Burchmore, M.; Shak, S.; Stewart, S. J.; Press, M. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J. Clin. Oncol., 2002, 20(3), 719-726.
6. Hartwell, L. H.; Szankasi, P.; Roberts, C. J.; Murray, A. W.; Friend, S. H. Integrating genetic approaches into the discovery of anticancer drugs. Science, 1997, 278(5340), 1064-1068.
7. Quon, K.; Kassner, P. D. RNA interference screening for the discovery of oncology targets. Expert. Opin. Ther. Targets, 2009, 13(9), 1027-1035.
8. Kamb, A.; Wee, S.; Lengauer, C. Why is cancer drug discovery so difficult? Nat. Rev. Drug. Discov., 2007, 6(2), 115-120.
9. Iorns, E.; Lord, C. J.; Turner, N.; Ashworth, A. Utilizing RNA interference to enhance cancer drug discovery. Nat. Rev. Drug. Discov., 2007, 6(7), 556-568.
10. Boutros, M.; Ahringer, J. The art and design of genetic screens: RNA interference. Nat. Rev. Genet., 2008, 9(7), 554-666.
11. Luo, B.; Cheung, H. W.; Subramanian, A.; Sharifnia, T.; Okamoto, M.; Yang, X.; Hinkle, G.; Boehm, J. S.; Beroukhim, R.; Weir, B. A.; Mermel, C.; Barbie, D. A.; Awad, T.; Zhou, X.; Nguyen, T.; Piqani, B.; Li, C.; Golub, T. R.; Meyerson, M.; Hacohen, N.; Hahn, W. C.; Lander, E. S.; Sabatini, D. M.; Root, D. E. Highly parallel identification of essential genes in cancer cells. Proc. Natl. Acad. Sci. USA, 2008, 105(51), 20380-20385.
12. Dykxhoorn, D. M.; Novina, C. D.; Sharp, P. A. Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell. Biol., 2003, 4(6), 457-467.
13. Meister, G.; Tuschl, T. Mechanisms of gene silencing by double-stranded RNA. Nature, 2004, 431(7006), 343-349.
14. Zamore, P. D.; Haley, B. Ribo-gnome: the big world of small RNAs. Science, 2005, 309(5740), 1519-1524.
15. Chapman, E. J.; Carrington, J. C. Specialization and evolution of endogenous small RNA pathways. Nat. Rev. Genet., 2007, 8(11), 884-896.
16. Ghildiyal, M.; Zamore, P. D. Small silencing RNAs: an expanding universe. Nat. Rev. Genet., 2009, 10(2), 94-108.
17. Lord, C. J.; Martin, S. A.; Ashworth, A. RNA interference screening demystified. J. Clin. Pathol., 2009, 62(3), 195-200.
18. Sharma, S.; Rao, A. RNAi screening: tips and techniques. Nat. Immunol., 2009, 10(8), 799-804.
19. Brummelkamp, T. R.; Nijman, S. M.; Dirac, A. M.; Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature., 2003, 424(6950), 797-801.
20. Oberdoerffer, S.; Moita, L. F.; Neems, D.; Freitas, R. P.; Hacohen, N.; Rao, A. Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL. Science, 2008, 321(5889), 686-691.
21. Wu, Z.; Jia, X.; de la Cruz, L.; Su, X. C.; Marzolf, B.; Troisch, P.; Zak, D.; Hamilton, A.; Whittle, B.; Yu, D.; Sheahan, D.; Bertram, E.; Aderem, A.; Otting, G.; Goodnow, C. C.; Hoyne, G. F. Memory T cell RNA rearrangement programmed by heterogeneous nuclear ribonucleoprotein hnRNPLL. Immunity, 2008, 29(6), 863-875.
22. Echeverri, C. J.; Perrimon, N. High-throughput RNAi screening in cultured cells: a user's guide. Nat. Rev. Genet., 2006, 7(5), 373-384.
23. Moffat, J.; Sabatini, D. M. Building mammalian signalling path-ways with RNAi screens. Nat. Rev. Mol. Cell. Biol., 2006, 7(3), 177-187.
24. Perrimon, N.; Mathey-Prevot, B. Applications of high-throughput RNA interference screens to problems in cell and developmental biology. Genetics, 2007, 175(1), 7-16.
25. Bernards, R.; Brummelkamp, T. R.; Beijersbergen, R. L. shRNA libraries and their use in cancer genetics. Nat. Methods, 2006, 3(9), 701-706.
26. Aza-Blanc, P.; Cooper, C. L.; Wagner, K.; Batalov, S.; Deveraux, Q. L.; Cooke, M. P. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol. Cell., 2003, 12(3), 627-637.
27. Murrow, L. M.; Garimella, S. V.; Jones, T. L.; Caplen, N. J.; Lipkowitz, S. Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome. Breast Cancer Res. Treat., 2010, 122(2), 347-357.
28. Bjorklund, M.; Taipale, M.; Varjosalo, M.; Saharinen, J.; Lahdenpera, J.; Taipale, J. Identification of pathways regulating cell size and cell-cycle progression by RNAi. Nature, 2006, 439(7079), 1009-1013.
29. Eggert, U. S.; Kiger, A. A.; Richter, C.; Perlman, Z. E.; Perrimon, N.; Mitchison, T. J.; Field, C. M. Parallel chemical genetic and genome-wide RNAi screens identify cytokinesis inhibitors and targets. PLoS. Biol., 2004, 2(12), e379.
30. Bettencourt-Dias, M.; Giet, R.; Sinka, R.; Mazumdar, A.; Lock, W. G.; Balloux, F.; Zafiropoulos, P. J.; Yamaguchi, S.; Winter, S.; Carthew, R. W.; Cooper, M.; Jones, D.; Frenz, L.; Glover, D. M. Genome-wide survey of protein kinases required for cell cycle progression. Nature, 2004, 432(7020), 980-987.
31. Gonczy, P.; Echeverri, C.; Oegema, K.; Coulson, A.; Jones, S. J.; Copley, R. R.; Duperon, J.; Oegema, J.; Brehm, M.; Cassin, E.; Hannak, E.; Kirkham, M.; Pichler, S.; Flohrs, K.; Goessen, A.; Leidel, S.; Alleaume, A. M.; Martin, C.; Ozlu, N.; Bork, P.; Hyman, A. A. Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature, 2000, 408(6810), 331-336.
32. Sonnichsen, B.; Koski, L. B.; Walsh, A.; Marschall, P.; Neumann, B.; Brehm, M.; Alleaume, A. M.; Artelt, J.; Bettencourt, P.; Cassin, E.; Hewitson, M.; Holz, C.; Khan, M.; Lazik, S.; Martin, C.; Nitzsche, B.; Ruer, M.; Stamford, J.; Winzi, M.; Heinkel, R.; Roder, M.; Finell, J.; Hantsch, H.; Jones, S. J.; Jones, M.; Piano, F.; Gunsalus, K. C.; Oegema, K.; Gonczy, P.; Coulson, A.; Hyman, A. A.; Echeverri, C. J. Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature, 2005, 434(7032), 462-469.
33. Kittler, R.; Pelletier, L.; Heninger, A. K.; Slabicki, M.; Theis, M.; Miroslaw, L.; Poser, I.; Lawo, S.; Grabner, H.; Kozak, K.; Wagner, J.; Surendranath, V.; Richter, C.; Bowen, W.; Jackson, A. L.; Habermann, B.; Hyman, A. A.; Buchholz, F. Genome-scale RNAi profiling of cell division in human tissue culture cells. Nat. Cell. Biol., 2007, 9(12), 1401-1412.
34. Bakal, C.; Aach, J.; Church, G.; Perrimon, N. Quantitative morphological signatures define local signaling networks regulating cell morphology. Science, 2007, 316(5832), 1753-1756.
35. Berns, K.; Horlings, H. M.; Hennessy, B. T.; Madiredjo, M.; Hijmans, E. M.; Beelen, K.; Linn, S. C.; Gonzalez-Angulo, A. M.; Stemke-Hale, K.; Hauptmann, M.; Beijersbergen, R. L.; Mills, G. B.; van de Vijver, M. J.; Bernards, R. A functional genetic approach identifies the PI3K pathway as a major determinant of tras tuzumab resistance in breast cancer. Cancer Cell, 2007, 12(4), 395-402.
36. Schlabach, M. R.; Luo, J.; Solimini, N. L.; Hu, G.; Xu, Q.; Li, M. Z.; Zhao, Z.; Smogorzewska, A.; Sowa, M. E.; Ang, X. L.; Westbrook, T. F.; Liang, A. C.; Chang, K.; Hackett, J. A.; Harper, J. W.; Hannon, G. J.; Elledge, S. J. Cancer proliferation gene discovery through functional genomics. Science, 2008, 319(5863), 620-624.
37. Silva, J. M.; Marran, K.; Parker, J. S.; Silva, J.; Golding, M.; Schlabach, M. R.; Elledge, S. J.; Hannon, G. J.; Chang, K. Profiling essential genes in human mammary cells by multiplex RNAi screening. Science, 2008, 319(5863), 617-620.
38. Root, D. E.; Hacohen, N.; Hahn, W. C.; Lander, E. S.; Sabatini, D. M. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat. Methods, 2006, 3(9), 715-719.
39. Brummelkamp, T. R.; Fabius, A. W.; Mullenders, J.; Madiredjo, M.; Velds, A.; Kerkhoven, R. M.; Bernards, R.; Beijersbergen, R. L. An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors. Nat. Chem. Biol., 2006, 2(4), 202-206.
40. Berns, K.; Hijmans, E. M.; Mullenders, J.; Brummelkamp, T. R.; Velds, A.; Heimerikx, M.; Kerkhoven, R. M.; Madiredjo, M.; Nijkamp, W.; Weigelt, B.; Agami, R.; Ge, W.; Cavet, G.; Linsley, P. S.; Beijersbergen, R. L.; Bernards, R. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature, 2004, 428(6981), 431-437.
41. Ngo, V. N.; Davis, R. E.; Lamy, L.; Yu, X.; Zhao, H.; Lenz, G.; Lam, L. T.; Dave, S.; Yang, L.; Powell, J.; Staudt, L. M. A loss-of-function RNA interference screen for molecular targets in cancer. Nature, 2006, 441(7089), 106-110.
42. Downward, J. Use of RNA interference libraries to investigate oncogenic signalling in mammalian cells. Oncogene, 2004, 23(51), 8376-8383.
43. Westbrook, T. F.; Stegmeier, F.; Elledge, S. J. Dissecting cancer pathways and vulnerabilities with RNAi. Cold. Spring Harb. Symp. Quant. Biol., 2005, 70, 435-444.
44. Scholl, C.; Frohling, S.; Dunn, I. F.; Schinzel, A. C.; Barbie, D. A.; Kim, S. Y.; Silver, S. J.; Tamayo, P.; Wadlow, R. C.; Ramaswamy, S.; Dohner, K.; Bullinger, L.; Sandy, P.; Boehm, J. S.; Root, D. E.; Jacks, T.; Hahn, W. C.; Gilliland, D. G. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell, 2009, 137(5), 821-834.
45. Hattori, H.; Zhang, X.; Jia, Y.; Subramanian, K. K.; Jo, H.; Loison, F.; Newburger, P. E.; Luo, H. R. RNAi screen identifies UBE2D3 as a mediator of all-trans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells. Blood, 2007, 110(2), 640-650.
46. Kolfschoten, I. G.; van Leeuwen, B.; Berns, K.; Mullenders, J.; Beijersbergen, R. L.; Bernards, R.; Voorhoeve, P. M.; Agami, R. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell, 2005, 121(6), 849-858.
47. Westbrook, T. F.; Martin, E. S.; Schlabach, M. R.; Leng, Y.; Liang, A. C.; Feng, B.; Zhao, J. J.; Roberts, T. M.; Mandel, G.; Hannon, G. J.; Depinho, R. A.; Chin, L.; Elledge, S. J. A genetic screen for candidate tumor suppressors identifies REST. Cell, 2005, 121(6), 837-848.
48. Gazin, C.; Wajapeyee, N.; Gobeil, S.; Virbasius, C. M.; Green, M. R. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature, 2007, 449(7165), 1073-1077.
49. Whitehurst, A. W.; Bodemann, B. O.; Cardenas, J.; Ferguson, D.; Girard, L.; Peyton, M.; Minna, J. D.; Michnoff, C.; Hao, W.; Roth, M. G.; Xie, X. J.; White, M. A. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature, 2007, 446(7137), 815-819.
50. Luo, J.; Elledge, S. J. Cancer: Deconstructing oncogenesis. Nature, 2008, 453(7198), 995-996.
51. Brass, A. L.; Dykxhoorn, D. M.; Benita, Y.; Yan, N.; Engelman, A.; Xavier, R. J.; Lieberman, J.; Elledge, S. J. Identification of host proteins required for HIV infection through a functional genomic screen. Science, 2008, 319(5865), 921-926.
52. Zhou, H.; Xu, M.; Huang, Q.; Gates, A. T.; Zhang, X. D.; Castle, J. C.; Stec, E.; Ferrer, M.; Strulovici, B.; Hazuda, D. J.; Espeseth, A. S. Genome-scale RNAi screen for host factors required for HIV replication. Cell. Host. Microb., 2008, 4(5), 495-504.
53. Li, Q.; Brass, A. L.; Ng, A.; Hu, Z.; Xavier, R. J.; Liang, T. J.; Elledge, S. J. A genome-wide genetic screen for host factors re quired for hepatitis C virus propagation. Proc. Natl. Acad. Sci. USA, 2009, 106(38), 16410-16415.
54. Tai, A. W.; Benita, Y.; Peng, L. F.; Kim, S. S.; Sakamoto, N.; Xavier, R. J.; Chung, R. T. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell. Host. Microbe, 2009, 5(3), 298-307.
55. Randall, G.; Panis, M.; Cooper, J. D.; Tellinghuisen, T. L.; Sukhodolets, K. E.; Pfeffer, S.; Landthaler, M.; Landgraf, P.; Kan, S.; Lindenbach, B. D.; Chien, M.; Weir, D. B.; Russo, J. J.; Ju, J.; Brownstein, M. J.; Sheridan, R.; Sander, C.; Zavolan, M.; Tuschl, T.; Rice, C. M. Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl. Acad. Sci. USA, 2007, 104(31), 12884-12889.
56. Hao, L.; Sakurai, A.; Watanabe, T.; Sorensen, E.; Nidom, C. A.; Newton, M. A.; Ahlquist, P.; Kawaoka, Y. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature, 2008, 454(7206), 890-893.
57. Krishnan, M. N.; Ng, A.; Sukumaran, B.; Gilfoy, F. D.; Uchil, P. D.; Sultana, H.; Brass, A. L.; Adametz, R.; Tsui, M.; Qian, F.; Montgomery, R. R.; Lev, S.; Mason, P. W.; Koski, R. A.; Elledge, S. J.; Xavier, R. J.; Agaisse, H.; Fikrig, E. RNA interference screen for human genes associated with West Nile virus infection. Nature, 2008, 455(7210), 242-245.
58. Qin, Q. M.; Pei, J.; Ancona, V.; Shaw, B. D.; Ficht, T. A.; de Figueiredo, P. RNAi screen of endoplasmic reticulum-associated host factors reveals a role for IRE1alpha in supporting Brucella replication. PLoS Pathog., 2008, 4(7), e1000110.
59. Sledz, C. A.; Holko, M.; de Veer, M. J.; Silverman, R. H.; Williams, B. R. Activation of the interferon system by short-interfering RNAs. Nat. Cell. Biol., 2003, 5(9), 834-839.
60. Agrawal, S.; Kandimalla, E. R. Role of Toll-like receptors in antisense and siRNA[corrected]. Nat. Biotechnol., 2004, 22(12), 1533-1537.
61. Birmingham, A.; Anderson, E. M.; Reynolds, A.; Ilsley-Tyree, D.; Leake, D.; Fedorov, Y.; Baskerville, S.; Maksimova, E.; Robinson, K.; Karpilow, J.; Marshall, W. S.; Khvorova, A. 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat. Methods, 2006, 3(3), 199-204.
62. Jackson, A. L.; Burchard, J.; Schelter, J.; Chau, B. N.; Cleary, M.; Lim, L.; Linsley, P. S. Widespread siRNA off-target transcript silencing mediated by seed region sequence complementarity. RNA, 2006, 12(7), 1179-1187.
63. Lin, X.; Ruan, X.; Anderson, M. G.; McDowell, J. A.; Kroeger, P. E.; Fesik, S. W.; Shen, Y. siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Res., 2005, 33(14), 4527-4535.
64. Echeverri, C. J.; Beachy, P. A.; Baum, B.; Boutros, M.; Buchholz, F.; Chanda, S. K.; Downward, J.; Ellenberg, J.; Fraser, A. G.; Hacohen, N.; Hahn, W. C.; Jackson, A. L.; Kiger, A.; Linsley, P. S.; Lum, L.; Ma, Y.; Mathey-Prevot, B.; Root, D. E.; Sabatini, D. M.; Taipale, J.; Perrimon, N.; Bernards, R. Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat. Methods, 2006, 3(10), 777-779.
65. Goodman, T. T.; Ng, C. P.; Pun, S. H. 3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers. Bioconjug. Chem., 2008, 19(10), 1951-1959.
66. Dykxhoorn, D. M. RNA interference as an anticancer therapy: a patent perspective. Expert. Opin. Ther. Pat., 2009, 19(4), 475-491.
67. Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S. The protein kinase complement of the human genome. Science, 2002, 298(5600), 1912-1934.
68. Tyner, J. W.; Deininger, M. W.; Loriaux, M. M.; Chang, B. H.; Gotlib, J. R.; Willis, S. G.; Erickson, H.; Kovacsovics, T.; O'Hare, T.; Heinrich, M. C.; Druker, B. J. RNAi screen for rapid therapeutic target identification in leukemia patients. Proc. Natl. Acad. Sci. USA, 2009, 106(21), 8695-8700.
69. Ebert, B. L.; Pretz, J.; Bosco, J.; Chang, C. Y.; Tamayo, P.; Galili, N.; Raza, A.; Root, D. E.; Attar, E.; Ellis, S. R.; Golub, T. R. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature, 2008, 451(7176), 335-339.
70. Turner, N. C.; Lord, C. J.; Iorns, E.; Brough, R.; Swift, S.; Elliott, R.; Rayter, S.; Tutt, A. N.; Ashworth, A. A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor. EMBO J., 2008, 27(9), 1368-1377.
71. Kaelin, W. G. Jr. The concept of synthetic lethality in the context of anticancer therapy. Nat. Rev. Cancer, 2005, 5(9), 689-698.
72. Giroux, V.; Iovanna, J.; Dagorn, J. C. Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance. FASEB J., 2006, 20(12), 1982-1991.
73. MacKeigan, J. P.; Murphy, L. O.; Blenis, J. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat. Cell. Biol., 2005, 7(6), 591-600.
74. Swanton, C.; Marani, M.; Pardo, O.; Warne, P. H.; Kelly, G.; Sahai, E.; Elustondo, F.; Chang, J.; Temple, J.; Ahmed, A. A.; Brenton, J. D.; Downward, J.; Nicke, B. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell, 2007, 11(6), 498-512.
75. Iorns, E.; Turner, N. C.; Elliott, R.; Syed, N.; Garrone, O.; Gasco, M.; Tutt, A. N.; Crook, T.; Lord, C. J.; Ashworth, A. Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer. Cancer Cell., 2008, 13(2), 91-104.
76. Wang, Q. Z.; Xu, W.; Habib, N.; Xu, R. Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr. Cancer Drug Targets, 2009, 9(4), 572-594.
77. Lowery, A. J.; Miller, N.; McNeill, R. E.; Kerin, M. J. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin. Cancer Res., 2008, 14(2), 360-365.
78. Voorhoeve, P. M.; le Sage, C.; Schrier, M.; Gillis, A. J.; Stoop, H.; Nagel, R.; Liu, Y. P.; van Duijse, J.; Drost, J.; Griekspoor, A.; Zlotorynski, E.; Yabuta, N.; De Vita, G.; Nojima, H.; Looijenga, L. H.; Agami, R. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell, 2006, 124(6), 1169-1181.
79. Ovcharenko, D.; Kelnar, K.; Johnson, C.; Leng, N.; Brown, D. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res., 2007, 67(22), 10782-10788.
80. Zhang, S.; Binari, R.; Zhou, R.; Perrimon, N. A genome-wide RNAi screen for modifiers of aggregates formation by mutant huntingtin in drosophila. Genetics, 2010, 184(4), 1165-1179.
81. Azorsa, D. O.; Robeson, R. H.; Frost, D.; Meechoovet, B.; Brautigam, G. R.; Dickey, C.; Beaudry, C.; Basu, G. D.; Holz, D. R.; Hernandez, J. A.; Bisanz, K. M.; Gwinn, L.; Grover, A.; Rogers, J.; Reiman, E. M.; Hutton, M.; Stephan, D. A.; Mousses, S.; Dunckley, T. High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation. BMC Genomics, 2010, 11(1), 25.
82. Sepp, K. J.; Hong, P.; Lizarraga, S. B.; Liu, J. S.; Mejia, L. A.; Walsh, C. A.; Perrimon, N. Identification of neural outgrowth genes using genome-wide RNAi. PLoS Genet., 2008, 4(7), e1000111.
83. Bond, D.; Foley, E. A quantitative RNAi screen for JNK modifiers identifies Pvr as a novel regulator of Drosophila immune signaling. PLoS Pathog., 2009, 5(11), e1000655.
84. Baeg, G. H.; Zhou, R.; Perrimon, N. Genome-wide RNAi analysis of JAK/STAT signaling components in Drosophila. Genes Dev., 2005, 19(16), 1861-1870.
85. Astier, A. L.; Beriou, G.; Eisenhaure, T. M.; Anderton, S. M.; Hafler, D. A.; Hacohen, N. RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels. J. Immunol., 2010, 184(2), 685-693.
86. Willingham, A. T.; Orth, A. P.; Batalov, S.; Peters, E. C.; Wen, B. G.; Aza-Blanc, P.; Hogenesch, J. B.; Schultz, P. G. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science, 2005, 309(5740), 1570-1573.
87. Cherry, S. What have RNAi screens taught us about viral-host interactions? Curr. Opin. Microbiol., 2009, 12(4), 446-452.
88. Haasnoot, J.; Berkhout, B. RNA interference: its use as antiviral therapy. Handb. Exp. Pharmacol., 2006(173), 117-150.
89. Boden, D.; Pusch, O.; Silbermann, R.; Lee, F.; Tucker, L.; Ramratnam, B. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res., 2004, 32(3), 1154-1158.
90. Ilves, H.; Kaspar, R. L.; Wang, Q.; Seyhan, A. A.; Vlassov, A. V.; Contag, C. H.; Leake, D.; Johnston, B. H. Inhibition of hepatitis C IRES-mediated gene expression by small hairpin RNAs in human hepatocytes and mice. Ann. N.Y. Acad. Sci., 2006, 1082, 52-55.
91. Seyhan, A. A.; Alizadeh, B. N.; Lundstrom, K.; Johnston, B. H. RNA interference-mediated inhibition of Semliki Forest virus rep lication in mammalian cells. Oligonucleotides, 2007, 17(4), 473-484.
92. Das, A. T.; Brummelkamp, T. R.; Westerhout, E. M.; Vink, M.; Madiredjo, M.; Bernards, R.; Berkhout, B. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol., 2004, 78(5), 2601-2605.
93. Westerhout, E. M.; Ooms, M.; Vink, M.; Das, A. T.; Berkhout, B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res., 2005, 33(2), 796-804.
94. Konig, R.; Zhou, Y.; Elleder, D.; Diamond, T. L.; Bonamy, G. M.; Irelan, J. T.; Chiang, C. Y.; Tu, B. P.; De Jesus, P. D.; Lilley, C. E.; Seidel, S.; Opaluch, A. M.; Caldwell, J. S.; Weitzman, M. D.; Kuhen, K. L.; Bandyopadhyay, S.; Ideker, T.; Orth, A. P.; Miraglia, L. J.; Bushman, F. D.; Young, J. A.; Chanda, S. K. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell, 2008, 135(1), 49-60.
95. Bushman, F. D.; Malani, N.; Fernandes, J.; D'Orso, I.; Cagney, G.; Diamond, T. L.; Zhou, H.; Hazuda, D. J.; Espeseth, A. S.; Konig, R.; Bandyopadhyay, S.; Ideker, T.; Goff, S. P.; Krogan, N. J.; Frankel, A. D.; Young, J. A.; Chanda, S. K. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog., 2009, 5(5), e1000437.
96. Karlas, A.; Machuy, N.; Shin, Y.; Pleissner, K. P.; Artarini, A.; Heuer, D.; Becker, D.; Khalil, H.; Ogilvie, L. A.; Hess, S.; Maurer, A. P.; Muller, E.; Wolff, T.; Rudel, T.; Meyer, T. F. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature, 2010, 463(7282), 818-822.
97. Ng, T. I.; Mo, H.; Pilot-Matias, T.; He, Y.; Koev, G.; Krishnan, P.; Mondal, R.; Pithawalla, R.; He, W.; Dekhtyar, T.; Packer, J.; Schurdak, M.; Molla, A. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology. Hepatology, 2007, 45(6), 1413-1421.
98. Supekova, L.; Supek, F.; Lee, J.; Chen, S.; Gray, N.; Pezacki, J. P.; Schlapbach, A.; Schultz, P. G. Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. J. Biol. Chem., 2008, 283(1), 29-36.
99. Noueiry, A. O.; Chen, J.; Ahlquist, P. A mutant allele of essential, general translation initiation factor DED1 selectively inhibits translation of a viral mRNA. Proc. Natl. Acad. Sci. USA, 2000, 97(24), 12985-12990.
100. Berger, K. L.; Cooper, J. D.; Heaton, N. S.; Yoon, R.; Oakland, T. E.; Jordan, T. X.; Mateu, G.; Grakoui, A.; Randall, G. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc. Natl. Acad. Sci. USA, 2009, 106(18), 7577-7582.
101. Sessions, O. M.; Barrows, N. J.; Souza-Neto, J. A.; Robinson, T. J.; Hershey, C. L.; Rodgers, M. A.; Ramirez, J. L.; Dimopoulos, G.; Yang, P. L.; Pearson, J. L.; Garcia-Blanco, M. A. Discovery of insect and human dengue virus host factors. Nature, 2009, 458(7241), 1047-1050.
102. Cronin, S. J.; Nehme, N. T.; Limmer, S.; Liegeois, S.; Pospisilik, J. A.; Schramek, D.; Leibbrandt, A.; Simoes Rde, M.; Gruber, S.; Puc, U.; Ebersberger, I.; Zoranovic, T.; Neely, G. G.; von Haeseler, A.; Ferrandon, D.; Penninger, J. M. Genome-wide RNAi screen identifies genes involved in intestinal pathogenic bacterial infection. Science, 2009, 325(5938), 340-343.
103. Pielage, J. F.; Powell, K. R.; Kalman, D.; Engel, J. N. RNAi screen reveals an Abl kinase-dependent host cell pathway involved in Pseudomonas aeruginosa internalization. PLoS Pathog., 2008, 4(3), e1000031.
104. Derre, I.; Pypaert, M.; Dautry-Varsat, A.; Agaisse, H. RNAi screen in Drosophila cells reveals the involvement of the Tom complex in Chlamydia infection. PLoS Pathog., 2007, 3(10), 1446-1458.
105. Agaisse, H.; Burrack, L. S.; Philips, J. A.; Rubin, E. J.; Perrimon, N.; Higgins, D. E. Genome-wide RNAi screen for host factors required for intracellular bacterial infection. Science, 2005, 309(5738), 1248-1251.
106. Mittal, V. Improving the efficiency of RNA interference in mammals. Nat. Rev. Genet., 2004, 5(5), 355-365.